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Abstract
The importance of excess salt intake in the pathogenesis of hypertension is widely recognized. Blood pressure is controlled
primarily by salt and water balance because of the infinite gain property of the kidney to rapidly eliminate excess fluid and
salt. Up to fifty percent of patients with essential hypertension are salt-sensitive, as manifested by a rise in blood pressure
with salt loading. We conducted a two-stage genetic analysis in hypertensive patients very accurately phenotyped for their
salt-sensitivity. All newly discovered never treated before, essential hypertensives underwent an acute salt load to monitor
the simultaneous changes in blood pressure and renal sodium excretion. The first stage consisted in an association analysis
of genotyping data derived from genome-wide array on 329 subjects. Principal Component Analysis demonstrated that this
population was homogenous. Among the strongest results, we detected a cluster of SNPs located in the first introns of
PRKG1 gene (rs7897633, p = 2.34E-05) associated with variation in diastolic blood pressure after acute salt load. We further
focused on two genetic loci, SLC24A3 and SLC8A1 (plasma membrane sodium/calcium exchange proteins, NCKX3 and NCX1,
respectively) with a functional relationship with the previous gene and associated to variations in systolic blood pressure
(the imputed rs3790261, p = 4.55E-06; and rs434082, p = 4.7E-03). In stage 2, we characterized 159 more patients for the
SNPs in PRKG1, SLC24A3 and SLC8A1. Combined analysis showed an epistatic interaction of SNPs in SLC24A3 and SLC8A1 on
the pressure-natriuresis (p interaction = 1.55E-04, p model = 3.35E-05), supporting their pathophysiological link in cellular
calcium homeostasis. In conclusions, these findings point to a clear association between body sodium-blood pressure
relations and molecules modulating the contractile state of vascular cells through an increase in cytoplasmic calcium
concentration.
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Introduction
Cardiovascular diseases are the major cause of health burdens
and costs worldwide and essential hypertension accounts for about
50 percent of them [1]. Epidemiological, clinical and experimental
studies support the relationship between dietary salt, renal salt
handling and blood pressure (BP), suggesting dietary sodium (Na+)
as an important contributor to hypertension [2]. However, BP
response to changes in salt intake, namely salt-sensitivity, is very
heterogeneous among individuals and is present in approximately
half of the hypertensives [3]. Most importantly, salt-sensitivity is a
negative prognostic indicator since it increases the risk for
cardiovascular complications and their prognostic target organ
damage indicators as left ventricular hypertrophy, microalbumin-
uria and endothelial dysfunction [4,5]. Body Na+ and BP
regulation is achieved through the interaction of several
mechanisms, starting from Na+ handling in kidney tubular cells,
moving to the myogenic tone at vascular level [6]. Further
influences due to physical, nervous, and hormonal factors
modulate this constitutive capacity of tubular cells to transport
Na+ according to the body’s needs [7].
Salt-sensitive hypertension is, at least in part, under genetic
control [8] but the underlying genetic mechanisms are not fully
clarified. Salt-sensitivity can be assessed with different standard-
ized protocols including acute salt load, chronic dietary sodium
depletion and chronic sodium volume depletion. Our group
performed a systematic analysis of the genetic mechanisms
involved in salt-sensitivity, using a well-standardized protocol,
consisting in the acute intravenous infusion of saline. So far we
have evidenced the genetic contribution of ADD1, ACE, WNK1
and NEDD4L variants to the acute BP response [9,10,11,12].
For the present, and the next steps, we decided to exploit a
technique alternative to the manual TaqMan, used previously, i.e.
that of low density genome-wide genotyping array. This has been
done not necessarily to have a complete view of all the genome,
but for the following two reasons: (i) to get rid of the uncertainty of
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potential hidden stratification that could affect the results and
correct for it, if needed; (ii) to have our data set genotyped once,
and to concentrate on a specific hypothesis that involves one
genetic mechanism or pathway at a time [13].
We are well aware that Genome-Wide Association studies
(GWAs) represent a powerful tool to explore variants associated to
complex traits and to evaluate possible gene-gene interactions
[14], but the huge number of samples needed to reach the
genome-wide threshold of significance cannot be realistically
applied to an endophenotype like salt-sensitivity, which requires
great care in measurement. In fact, among the studies published so
far on the genetics of essential hypertension [15,16,17,18,19,20],
no GWA data are available on the genetics of salt-sensitive
hypertension.
Here, we report an association analysis with a genome-wide
genotyping array (stage 1) in a selected population of limited
sample size but consisting on mild hypertensive Caucasians who
underwent an acute salt load with the aim to search for genes
related to BP changes after this manoeuvre. Large-scale
genotyping enabled a systematic analysis of genetic susceptibility
to salt-sensitive hypertension and possible imputation. The
genome-wide genotyping data were also used to perform a
Principal Component Analysis (PCA) to assess the genetic
variance between the samples. After genomic control, PCA
analysis demonstrated that this population was homogeneous.
Among the strongest results we identified genes that code for
proteins involved in the vasoconstriction/dilation system at
different levels. The relevant SNPs were replicated in an
additional cohort (stage 2) and in the combined analysis. The
genes identified, PRKG1, SLC24A3 and SLC8A1, influence the
vascular tone likely through an increase in the concentration of
cytoplasmic calcium (Ca2+), and may represent a significant key
node for systemic BP regulation.
Results
We performed an association analysis with a genome-wide
genotyping array (stage 1) for three quantitative traits (DDBP120,
DSBP120 and PNat120; see Methods for details) measured in a
subset of hypertensive patients (n = 329) who underwent an acute
salt load. The three quantitative traits showed a normal
distribution. Subsequently, in stage 2, as replication, we genotyped
only the SNPs found significantly associated in stage 1 in 159 other
hypertensives who underwent the same test. These data were then
evaluated in a combined analysis. The clinical characteristics of all
subjects are shown in Table 1.
Association analyses in stage 1
Genome-wide genotyping array allowed to screen a huge
number of genetic nucleotide variations simultaneously and to
perform a genomic control of the first set of 329 subjects (stage 1).
PCA method is applied to large-scale association studies based on
SNP both to quantify population relationships and to correct for
population stratification [21,22]. PCA identified two outlier
individuals that were subsequently excluded from the study, thus
indicating that population stratification was negligible (Figure 1).
In addition, the test of population homogeneity confirmed that our
population was homogeneous, as the clusterization of individuals
was not significant (lambda= 1.0032 for DDBP120, lambda =
1.0044 for DSBP120 and lambda=1.0008 for PNat120). PCA was
also performed including Tuscans and Utah residents with
Northern and Western European ancestry population of HapMap
data and our cohort resulted in a perfect overlap with the Italian
population (Figure S1).
After quality control (Table S1), we analyzed 293,195 SNPs
(MAF$0.05) in 319 subjects. First, we tested all SNPs using an
unbiased association design. Mainly considering the limited
sample size and the practical impossibility to increase its size, we
used an adaptive permutation procedure to control the type I error
[23].
Among the top ranking association signals we first annotated
SNPs mapping in well-characterized molecules affecting BP or in
genes previously found associated with BP. After whole analysis,
we focused on SNPs and genes involved in the control of
cytoplasmic Ca2+ concentration, being the control of vascular tone
a key node for systemic BP regulation. Table 2 reports the
association of SNPs in PRKG1 and SLC24A3 genes associated with
DDBP120, DSBP120 and PNat120.
PRKG1. Three SNPs in PRKG1 gene (rs1904694, rs7897633
and rs7905063), spanning 59 kb from intron 1 to intron 2 at
10q11.23, showed a striking cluster of association with DDBP120
(p value = 8.17E-05, 2.34E-05 and 9.67E-05 under additive
genetic model, respectively) (Figure S2). The effect size on DBP
variation (beta coefficient) for each copy of susceptibility allele for
Table 1. Clinical characteristics of 474 patients underwent an
acute test of salt loading.
Mean±s.d.
Sex (m/f) 401/73
Age (years) 51.4610.6
BMI (kg/m2) 25.963
24 h SBP day-time (mmHg) 143.2612.3
24 h DBP day time (mmHg) 93.869.5
24 h Ur. Na+ (mEq/L) 144.2669
24 h Ur. K+ (mEq/L) 58.7623.3
DSBP120 4.369.7
DDBP120 266.5
Abbreviations: BMI, body mass index; Ur. Na+ and Ur. K+, urinary Na+ and K+
excretion; 24 h refers to 24 hour Ambulatory BP monitoring measurements.
doi:10.1371/journal.pone.0019620.t001
Figure 1. Multidimensional scaling plot of stage 1 cohort.
Individuals in red circle were identified as outliers and subsequently
excluded. The two principal components are plotted on the axis.
doi:10.1371/journal.pone.0019620.g001
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salt-sensitivity ranged from 1.87 to 2.06 mmHg (Table 2). PRKG1
codes for type I cGMP-dependent protein kinase, a
nitrovasodilator effector that has been shown to mediate
vascular smooth muscle cells (VSMC) relaxation by lowering
intracellular Ca2+level [24,25].
LD block and tagging analysis (r2$0.9) of the three PRKG1 top
SNPs in our samples indicated that they map in different
haplotype blocks (Figure S3). Particularly, rs7897633 SNP did
not show any proxy and the other two SNPs did not result in LD
with known informative polymorphisms, as well, according to
CEU HapMap Phase II reference panel. We next used imputation
to expand the set of investigated SNPs and search for possible
functional variants. None of the 655 imputed SNPs gave better
signals of association.
Comparative analysis revealed a high conservation of the A
allele of rs7897633 within a moderately conserved flanking
intronic region, denoting the ancestral nature of this nucleotide
(Figure S4). Interestingly, the A allele is the risk allele for salt-
sensitive response to Na+ intake (DDBP120 in AA +4.7360.71,
mean6se), whereas the protective C allele did not significantly
influence BP response to salt load (DDBP120 in CC +0.6760.67,
mean6se) and appears only in humans. Moreover, in HapMap
populations the C allele is present at high frequency (,0.50) both
in Europeans and in Asians, and at very low frequency in Africans
(http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs = rs7897633).
SLC24A3. A subsequent analysis also revealed a top ranking
SNP, rs6112470, in intron 4 of SLC24A3 gene and associated to
both DSBP120 (p = 4.28E-05; effect size = 4.7561.15 mmHg) and
PNat120 (p = 6.39E-04; effect size = 0.01560.004 mEq/mmHg/
min) under additive genetic model, with a salt-sensitive effect of
minor C allele (Table 2). SLC24A3 codes for the NCKX3, the
potassium dependent Na+/K+/Ca2+ exchanger type 3, an
important regulator of intracellular calcium homeostasis [26].
Pairwise correlation in HapMap CEU (r2.0.9) of rs6112470
included other six SNPs in nearby intron 3 and 4. When we
enlarged the analysis to the complete gene region, a cluster of
association of SNPs spanning 526 kb starting from the end of
intron 2 till mid intron 5 was identified even if with a p value range
(7.8E-03_1.1E-04) (Figure S5). Imputing revealed that among the
394 SNPs examined across this region, the imputed SNP
rs3790261 had the strongest association signal with DSBP120
(p = 4.55E-06), compared to any of the initial top ranking SNPs.
Pairwise correlation between the original and the imputed SNP
was 0.832 (r2) calculated on our dataset. As rs3790261 is a
synonymous change located at position +20 of exon 4 (c.369G.A),
we performed an in silico analysis with ESEfinder, and we observed
that the minor G allele abolished an exonic splicing enhancer
(ESE) for SRp40 binding site (Figure S6). We then considered
rs3790261 for further analysis.
SLC8A1. SLC8A1, that codes for Na+/Ca2+ exchanger type 1
NCX1 is one of the best candidate molecule in the biochemical
control of peripheral vascular resistance and its role in the
pathogenesis of hypertension and salt-sensitivity has been
previously demonstrated [27]. It belongs to plasma membrane
Na+/Ca2+ exchange proteins, with similar physiologic
characteristics to NCKX3, except for K+ dependence [28].
Therefore, it was obvious to look at our association results for
SLC8A1 in order to extend previous findings. An interesting cluster
of association with more than one quantitative trait was identified.
The statistically significant association between rs434082 and
DSBP120 was specific for this trait (p = 4.7E-03), while rs11893826
was also associated to PNat120 (p = 0.018) and had the weaker r2
in relation to rs434082 (Table 3). Particularly, all these SNPs are
located within the long intron 1 covering a region of about 105 kb,
and LD pattern reported in Figure S7 refers to canonical matrix
with high recombination rate. For each significant SNP a
functional proxy was searched with imputation, without
improving the results.
Stage 2 Association and Combined analyses
In stage 2 we performed genotyping in an additional population
of 159 subjects, for SNPs in PRKG1 (rs1904694, rs7897633,
rs7905063), SLC24A3 (rs3790261) and in SLC8A1 (rs11893826,
rs434082). As shown in Table S2, we did not obtain any significant
association except for PRKG1 locus, reflecting the limited power of
such a small cohort, though the trend of the allelic effect was
maintained across the two-stage studies.
Being the selection criteria of the patients the same between
stage 1 and 2, we performed a combined analysis. As we observed
some differences for sex, age, BMI between patients of the two
stages, results were adjusted for these variables. Regression analysis
on the combined data revealed an effect size on SBP variation
(beta coefficient) for each copy of susceptibility allele for salt-
sensitivity of 3.67 mmHg for rs3790261 (G compared to A) in
SLC24A3 (p = 2.97E-05), 1.87 mmHg, and 3.16 mmHg SBP for
SLC8A1 rs11893826 (A compared to G - p = 5.81E-03) and
rs434082 (A compared to G - p = 8.51E-04), respectively. For
PRKG1 SNPs the effect size was 1.36 mmHg on DBP change for
Table 2. Association of top ranking SNPs in PRKG1 and SLC24A3 with DDBP120, DSBP120, PNat120 in stage 1 (n = 319).
PRKG1 SLC24A3
Top SNP rs1904694 rs7897633 rs7905063 rs6112470
position (chr) 52905494 (10) 52957721 (10) 52964590 (10) 19562579 (20)
risk allele (frequency) G (0.42) A (0.52) T (0.53) C (0.15)
Regression coefficient (p value)
DDBP120 1.9560.49 (8.17e-05) 2.0660.48 (2.34e-05) 1.8760.47 (9.67e-05) ns
DSBP120 ns 1.6860.77 (0.029) 1.6260.76 (0.033) 4.7561.15 (4.28e-05)
PNat120 ns ns ns 0.01560.004 (6.39e-04)
Data generated by Plink assuming an additive genetic model, with a p-value smaller than E-04 for at least one of the phenotypes analyzed. Permutation was performed
and maintained the same robustness of significance.
Effect sizes are on the mmHg scale (6s.e.) (except for PNat120, mEq/mmHg/min) for increasing copy of the risk allele as estimated by the beta coefficient in linear
regression.
Position on chromosome refers to 37.1 Genome Build of GRCh37 (http://www.ncbi.nlm.nih.gov/SNP).
doi:10.1371/journal.pone.0019620.t002
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rs1904694 (G compared to A - p = 1.50E-03), whereas rs7897633
(A compared to C) and rs7905063 (T compared to C) exhibited
similar effect sizes of 1.86 and 1.84 mmHg (p= 1.28E-05 and
1.90E-5) respectively (Table 4). For these last SNPs the risk allele
was the most frequent.
The likely increased activity of both Ca2+ cotransporters due to
the susceptibility alleles for salt-sensitivity has been evaluated in
all population. No difference was observed if we examined total
plasma Ca2+. We then analyzed the effect of SLC8A1 rs11893826
and SLC24A3 rs3790261 variants in relation to urinary Ca2+
excretion (expressed as UCa2+/urinary creatinine*plasma creat-
inine, mg/100 ml of glomerular filtration rate, GFR): the former
resulted significantly associated at t 120 after Na+ load (non risk
GG 4.7560.31 vs risk GA+AA 3.7060.16 mg/100 ml GFR,
p = 0.001), indicating a reduced Ca2+ excretion for susceptibility
variant. Similar results were observed for SLC24A3 rs3790261
both at t 0 (non risk AA 2.2560.18 vs risk AG+GG
1.5860.16 mg/100 mL GFR, p = 0.021), and t 120 (non risk
AA 4.3560.21 vs risk AG+GG 3.6760.23 mg/100 ml GFR,
p = 0.045).
Interaction analyses
The vascular tone is determined by a certain number of proteins
that are part of a common pathway regulating force generation by
the actin-myosin-based contractile apparatus of the cell. Abnor-
malities of this system can cause primary changes in VSMC tone
and affect BP. Therefore, we searched for potential interactions
(i.e., deviation from an additive model) in the complete data set
among the genes identified as significantly associated to BP
changes after salt load in single SNP association.
In 2-SNP analyses, assuming a dominant genetic model, we
observed a significant interaction between rs3790261 in SLC24A3
and rs11893826 in SLC8A1 affecting absolute changes in SBP and
Na+ excretion in response to 120 minutes of salt loading
(PNat120) (p interaction = 1E-03, p model = 9.12E-05) (Figure 2).
The slope of the pressure-natriuresis relationship was less steep in
patients who carried both minor alleles (AG/GG for rs3790261
and GA/AA for rs11893826; 0.03160.005 mEq/mmHg/min 6
se) than in those carrying the remaining genotype combinations
(0.01060.002 mEq/mmHg/min 6 se) (p interaction = 1.55E-04,
p model = 3.35E-05 in dummy analysis). The significantly
different slopes of the two curves indicate that a larger increase
of SBP was needed in carriers of both minor (risk) alleles to
excrete the same amount of Na+, i.e. such subjects are salt-
sensitive.
Discussion
We conducted an association analysis on BP response to an
acute salt infusion in a subset of accurately phenotyped
hypertensive patients. This manoeuvre allows to monitor the
simultaneous changes in BP and renal Na+ excretion to evaluate
their relationship and to define the individual salt-sensitive
condition. Two different methods are mainly used to diagnose
salt-sensitivity: acute intravenous saline load and changes in
dietary salt intake, generally from high NaCl intake (300 mEq/die)
to low Na (,40 mEq/day) for 7 to 14 days [29]. In the latter
method a low compliance is more frequent than in acute sodium
load because strict dietary manipulations are difficult to achieve.
This is a relevant point because it can affect the accuracy of
diagnosis.
The present study is a two-stage analysis: we used a genome-
wide genotyping array in the first set of subjects (stage 1) primarily
to verify the homogeneity of our population by several statistical
analysis like PCA, homogeneity test, and to perform imputation as
a huge number of nucleotide variations were screened simulta-
neously. Stage 2 can be considered a replication of the first one,
though all patients were enrolled in our clinical unit.
In stage 1 we obtained some appealing results concerning
variants in genes involved in vasoconstrictor/dilator processes.
The genes we focused on, PRKG1, SLC24A3 and SLC8A1, regulate
intracellular Ca2+ concentration and through this mechanism can
Table 3. Candidate SNPs in SLC8A1 significantly associated
with DSBP120 (A), and LD r2 pattern between the best
associated SNP (rs434082) and the other SNPs (B).
A
rs434082 rs11893826
position 40485074 40564647
risk allele (frequency) A (0.08) A (0.40)
Regression coefficient (p value)
DSBP120 3.561.23 (0.0047) 2.1560.86 (0.012)
PNat120 ns 0.00860.003 (0.018)
B
SNP r2# rs434082
rs666362 0.702
rs487119 0.229
rs403630 0.133
rs10490053 0.067
rs727477 0.066
rs6544318 0.056
rs4952404 0.042
rs11893826 0.006
(A) Data generated by Plink assuming an additive genetic model. Permutation
was performed and maintained the same robustness of significance. Effect sizes
are on the mmHg scale (6s.e.) (except for PNat120, mEq/mmHg/minute) for
increasing copy of the risk allele as estimated by the beta coefficient in linear
regression.
Position on chromosome 2 refers to 37.1 Genome Build of GRCh37 (http://www.
ncbi.nlm.nih.gov/SNP).
(B) #Linkage Disequilibrium between rs434082 and other SNP associated with
DSBP120 trait.
doi:10.1371/journal.pone.0019620.t003
Table 4. Association of SNPs in PRKG1, SLC24A3 and SLC8A1
with DDBP120, DSBP120 in combined analysis (n = 478).
Gene SNP risk allele beta (se) p value phenotype
PRKG1 rs1904694 G 1.36 (60.43) 1.50E-03 DDBP120
rs7897633 A 1.86 (60.42) 1.28E-05 DDBP120
rs7905063 T 1.84 (60.43) 1.90E-05 DDBP120
SLC24A3 rs3790261 G 3.67 (60.87) 2.97E-05 DSBP120
SLC8A1 rs11893826 A 1.87 (60.67) 5.81E-03 DSBP120
rs434082 A 3.16 (60.94) 8.51E-04 DSBP120
Effect sizes are on the mmHg scale (6s.e.) for increasing copy of the risk allele
as estimated by the beta coefficient in linear regression based on the additive
genetic model.
Data adjusted for sex, age, BMI and stage.
doi:10.1371/journal.pone.0019620.t004
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control vascular tone that is a key node for systemic BP regulation
[6,7]. First, we found a strong association with variation in DBP
after acute salt load for a cluster of SNPs mapping in the first
introns of PRKG1 gene. This association was then confirmed in the
combined analysis (rs7897633, p = 1.28E-05). Second, a detailed
annotation of top ranking SNPs identified SLC24A3 and SLC8A1
associated to variation in SBP (the imputed rs3790261, p = 2.97E-
05; and rs434082, p = 8.51E-04). Both genes code for plasma
membrane Na+/Ca2+ exchange proteins (NCKX3 and NCX1,
respectively) with similar physiologic characteristics, except for K+
dependence. This physiological link was also supported by a
significant epistatic genetic interaction between the two loci on
PNat120 in the combined analyses. Only carriers of the risk alleles,
the minor alleles in both cases, showed a salt-sensitive pressure-
natriuresis curve (p interaction = 1.55E-04, p model = 3.35E-05).
These results suggest that BP modifications acutely induced by
the salt load involve genes regulating contractility of the VSMC
either through an increase in intracellular free Ca2+ concentration
or through an increased sensitivity to Ca2+ of the contractile
elements in response to various signalling events. Indeed, Ca2+
plays a central role in controlling vascular tone, thereby making
significant contributions to the regulation of systemic BP [30,31].
The most interesting SNP of our study, both in terms of
association and possible evolutionary impact, is rs7897633 at
PRKG1 locus. In fact, the A allele, the risk allele for salt-sensitivity,
reflects the ancestral status, whereas the protective C allele is
present exclusively in humans and is more frequent in non-African
populations. Other variants in genes involved in the control of
sodium homeostasis (AGT and CYP3A5 genes) show a similar
pattern: ancestral alleles are linked with an increased risk to
hypertension and are fixed in several primates, while the derived
protective alleles appear to carry the signature of positive natural
selection with a quick raise to high frequency [32].
PRKG1 encodes for the type 1 cGMP-dependent protein kinase
(cGKI), a nitrovasodilator effector widely distributed in eukary-
otes. Examining gene expression pattern in cultured VSMCs,
Tamura et al [33] detected an abundant human alpha subtype
mRNA in the aorta, heart, kidney and adrenals. The alpha and
beta isoforms that differ in their amino termini, exert their
simultaneous activity as mediators of smooth muscle tone
relaxation in vascular and nonvascular smooth muscle. cGKIs
are modulators of cell growth as well. Changes in vascular
morphology and tone can increase vascular resistance and BP
[34], and may alter cardiac contractility and remodelling. A recent
study indicates that PRKG1 impinges on circadian rhythms,
influencing a multitude of physiological processes such as
cardiovascular activity [35]. Another study in a Chinese
population supported the hypothesis that the abnormalities of
VSMCs that alter the intrinsic contractile state of the cell can
directly cause abnormal vascular tone and disorders of BP
regulation [36]. In this study a four-gene interaction model of
association that includes PRKG1 was found to affect the risk for
essential hypertension [36]. A conventional deletion of the gene for
cGKI has been studied in mice and multiple phenotypes, including
elevated BP, have been observed [37]. Mice with a selective
mutation in the N-terminal protein interaction domain of cGKI-
alpha display inherited vascular smooth muscle cell abnormalities
of contraction, abnormal relaxation of large and resistance blood
vessels, and increased systemic BP [34]. These mice express
mutant cGKI-alpha protein that is incapable of binding to myosin
light chain phosphatase, one key protein of vascular smooth
muscle cell (VSMC) contractile apparatus. From these data we
expected that PRKG1 gene does not directly affect renal sodium
transport, despite we observed a significant association with the
difference in DBP after acute Na load. Particularly, the risk alleles
may influence the vascular tone likely through an abnormal
elevation in vascular smooth muscle tone, leading to smooth
muscle dysfunction.
The intronic SNP rs6112470 in SLC24A3 is associated to SBP
variation in our study. However, from the functional point of view,
the most informative SNP was the imputed rs3790261 in exon 4,
since it resulted in an effect size on BP of 3.67 (p = 2.97E-05). Due
to its synonymous nature it may be included in a specific short
oligonucleotide sequence that affects exon splicing. ESEs within
exons promote splicing of the corresponding exons and subsequent
exclusion mediated by splicing regulatory proteins [38,39]. An in
Figure 2. Renal pressure-natriuresis relationship during acute salt load according to the rs3790261 (SLC24A3), rs11893826 (SLC8A1)
genotypes. Urinary sodium excretion (UNa+) as a function of SBP, at basal level (t 0) and after salt load (t 120). The pressure-natriuresis curve is drawn
in the left panel considering SLC8A1, rs11893826 polymorphism (carriers of the non risk allele G, green slope, and carriers of the risk allele A, orange
slope), in the genetic background of the non risk SLC24A3 AA genotype at rs3790261. It is drawn in the right panel considering the same genotypes
for SLC8A1, but within the genetic context of the risk SLC24A3 G allele at rs3790261. The significantly less steep slope of the orange line in the right
panel, compared to the three other slopes indicates the need for BP increase in order to excrete the salt load in carriers of that specific allele
combination.
doi:10.1371/journal.pone.0019620.g002
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silico search for inclusion of this polymorphism in a putative ESE
for SRp40 binding site suggests that rs3790261 may affect the
posttranscripional regulation of SLC24A3 mRNA, thus represent-
ing a RNA splicing signal. Further experimental settings are
needed to validate this hypothesis.
SLC24A3 encodes for NCKX3, one of the six isoforms of Na+/
K+/Ca2+ exchanger family, and can operate either in forward and
in reverse mode, depending on both ion gradients and the
membrane potential. Consequently, it represents one of the major
contributors in regulating Ca2+ flux in environments that
experience wide and frequent fluctuations in Na+ concentration
[26,28]. A recent gene expression microarray analysis in mice
demonstrated that NCKX3 is expressed in the kidney, where it is
primarily localized in the basolateral layer of the distal convoluted
tubules, with no detectable expression in the glomerulus and
proximal convoluted tubules, thus participating in active calcium
transport in the kidney [40]. NCKX3 was previously described in
various mammalian tissues, such as almost all regions of the brain,
in aorta, uterus, and skeletal muscle [41].
SLC8A1 gene may be phenotypically correlated with SLC24A3
because it codes for NCX1 transporter. Its role in the pathogenesis
of hypertension and sodium-sensitivity [27] has been already
demonstrated and makes it one of the best candidate molecule in
the biochemical control of peripheral vascular resistance. Indeed,
we found a significant association with SBP variation for a cluster
of intronic SNPs. NCX1 is abundantly expressed in kidney, heart,
brain and smooth cells. In particular, mice with genetically
engineered NCX1 proved that it contributed to long-term BP
regulation resulting in increased BP when it is over expressed, or
alternatively reduced BP in knockout [42]. Accordingly, a
significant association with SBP and hypertension regarded
SLC8A1 locus in a recent study of candidate genes for BP
regulation in KoraS3 cohort [13].
Our association results can also be considered as true positive
on biological grounds. In fact, a common biological pathway for
NCX1 and NCKX3 is shown as both genes are associated with
the same phenotypic trait (variation in SBP after salt load) and
display an epistatic interaction that affects PNat120. This is
important since polygenic multifactorial diseases are likely caused
by many alleles that confer a small individual effect but a high
risk in combination. Therefore, a combined analysis with
different SNPs exploring possible interactions can add interesting
information. The variations in intracellular Ca2+ are involved in
the vascular and tubular response to salt load [27]. Therefore,
our results showing the influence of the polymorphisms of genes
encoding Ca2+ transport system are consistent with these
pathophysiological data. In this study we did not address Ca2+
renal excretion issues, but a preliminary analysis showed no
association of SLC8A1 and SLC24A3 with the total plasma Ca2+.
However, if urinary Ca2+ excretion was examined, a significant
association was obtained for both exchanger variants (rs3790261
and rs11893826) at the end of infusion and at basal time only for
SLC24A3, clearly indicating a reduced Ca2+ excretion caused by a
likely gain of function of both risk variants of these cotransporters.
To convey this important issue further study will be required on
Ca2+ renal handling.
In the present study careful attention was paid to selection and
phenotyping of the hypertensive patients and the same criteria
were applied in stage 1 and stage 2 of the study. Only newly
discovered and consequently never treated hypertensive patients
were enrolled. These stringent selection criteria allowed excluding
the confounding effects of antihypertensive therapy and hyper-
tension duration. In most established association and GWA studies
published so far, BP values reported are biased by the
antihypertensive treatment ignoring the therapy or solving by
adding 10–15 mmHg to the observed BP values, because the need
of very large sample sizes doesn’t always allow detailed enrolment
[19,20,43]. The duration of hypertensive status is also important
since the pathophysiological mechanisms of hypertension or organ
damage are phase dependent [44]. Moreover, we performed a
genomic analysis on whole genome data and demonstrated that
our cohort was homogeneous and perfectly overlapping with
another Italian cohort.
A limitation of our study is the small sample size that reflects on
the weak association signals. This can certainly impact the results
of the genetic interactions that are also dependent on large data-
sets [45]. However, this limitation could be in part overcome by
the use of a well characterized intermediate phenotype measurable
as quantitative trait, that can add a considerable power compared
to typical case-control approaches [46]. In fact, an intermediate
phenotype (or endophenotype) of essential hypertension can help
to reduce the number of genetic and environmental confounding
interferences and increases the chance to identify the genetic
variants that influence the phenotype [47].
In summary, our study reports an association analysis of
genotyping data derived from genome-wide array on the BP
response to salt load. We identified a cluster of variations
associated with changes in both diastolic (rs1904694, rs7897633
and rs7905063) and systolic BP (rs3790261, rs434082 and
rs11893826) consequent to salt load. The associated SNPs map
in PRKG1, SLC24A3 and SLC8A1 that are involved in the
vasocostriction/dilation system. The understanding of the molec-
ular pathways involved in BP response to acute salt load provides
new knowledge for possible mechanisms leading to cardiac and
cerebral organ damage. Furthermore, these findings can help to
classify hypertension into sub-phenotypes based on genotypic data
for a gene-driven personalized therapy.
Materials and Methods
Overall study design
This study was arranged in two stages: 329 patients underwent
the acute salt loading test and were included in the discovery stage
(stage 1). Subsequently, further 159 patients underwent the same
salt loading test and were genotyped to confirm specific initial
findings (stage 2). Data from the two cohorts were combined to
provide a robust estimate of effect size for SNPs associated in stage
1. The San Raffaele Ethics Committee approved the study and all
participants gave the written informed consent.
All patients were newly discovered, never treated hypertensives
enrolled in the ‘Outpatient Clinic for Hypertension’ of San
Raffaele Hospital of Milan. In our selection criteria [48] we
excluded women taking estroprogestinic pill, resulting in a low
percent of women included in the study. Moreover, secondary
forms of hypertension were ruled out by routine examinations. All
individuals underwent an acute test of salt loading following the
enrolment criteria of mean day-time SBP$135 or
DBP$85 mmHg at 24 hours ambulatory blood pressure moni-
toring, age 18–65 years, and BMI,30 kg/m2. During a run-in
period of 3–5 weeks, the patients were instructed to keep a
constant Na+ intake of 150 mEq/24 h (which is the average Na+
intake observed in Milano [48]). Each patient collected 24 h urine
for analysis of compliance to the diet on the day before hospital
admission. Clinic basal BP as in-patient was recorded in the same
morning when blood samples for plasma renin activity and
aldosterone were drawn (on the day before the salt load). The
study protocol for acute salt load test was similar to that previously
reported [48].
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The slope of the relationship between SBP and Na+ excretion
(PNat pressure-natriuresis relationship, mEq/mmHg per minute)
was calculated by plotting the Na+ excretion on the y axis as a
function of SBP on the x axis measured both under basal
conditions (time 0= t 0) and after 2 hours of salt infusion (time
120= t 120), as described elsewhere [10].
Phenotype and Genotyping
For the analysis of association two main groups of phenotypes
were used: 1) BP phenotype – DDBP120 or DSBP120 is the
difference between Diastolic/Systolic BP at the end of salt load (at
time 120) and at baseline (at time 0); 2) Pressure-natriuresis
phenotype – PNat120 is the ratio between the DSBP120 and total
Na+ excretion amount from baseline to 120. All phenotypes were
analyzed as quantitative trait.
Genomic DNA was extracted from peripheral blood with
standard method. Patients from stage 1 were genotyped with the
Illumina (San Diego, CA) Infinium II HumanHap300 Duo
BeadChips. The 318,237 tagSNPs on this chip are taken from
Phase II of International HapMap Project and provide 80%
coverage of common variation in European population (r2 = 0.80).
The 9,035 SNPs on chromosome X are not included in this
analysis. In total, 309,202 autosomal SNPs were genotyped.
Mean call rate per individual was 0.983; 2 of 329 individuals
were removed for low genotyping (call rate,0.1). 5,437 SNPs with
genotyping rate .0.1 (% SNPs not called) and 10,031 SNPs with
MAF,0.05 were not included in the analysis. 1,876 markers failed
Hardy-Weinberg (HW) test (p#0.001). However, being our
sample composed only by cases we did not apply any HW filter
because these SNPs could be potentially causal. After frequency
pruning and quality control the analysis was done on 293,195
SNPs for 319 samples (Table S1).
A further genotyping quality control was obtained by compar-
ing genotypes obtained from the genotyping array mentioned
above to those previously generated for the stage 1 samples in
other studies (NEDD4L rs4149601 [10]; ADRB2 rs1042713 and
AGT rs699, not published). All these genotypes resulted in total
agreement with the previous data obtained with other technique.
Genotyping in stage 2 was performed with the 59 nuclease allelic
discrimination assays, with allele-specific MGB probes (TaqMan
SNP Genotyping Assay-Applied Biosystems, Foster City, CA,
USA).
Missing genotypes were imputed with MACH version 1.0
(Markov Chain based haplotyper) [49]. Reference genome
sequence for the imputation was downloaded from the Interna-
tional HapMap Project web site (HapMart) for both the CEU
(Utah residents with Northern and Western European ancestry
from the CEPH collection), and TSI (Tuscans in Italy) population.
Statistical analysis
Univariate linear regression analyses were carried out using an
additive genetic model of each filtered SNP using the statistical
with package PLINK version 1.06 [50]. This kind of analysis is
performed on the genotypic frequencies using different types of
statistical tests. Furthermore, to avoid false positive findings (type I
error) we requested adaptive permutations based on the Wald
statistics [50]. Population stratification assessment was performed
using PCA of eigenstrat and MDS as implemented in PLINK.
Association analysis in stage 2 was tested using one-way
ANOVA under an additive genetic model. In combined analysis,
we used General linear model (GLM) univariate analysis with
continuous phenotypes as dependent variable, semi-continuous
SNP genotype as independent variable under an additive model
and study stage, sex, age and BMI as covariates for adjustment.
Each associated SNP was fitted in regression analysis as a linear
term: the effect (beta) on BP in mmHg and on PNat in mEq/
mmHg/min of the risk allele for Na+ sensitivity was assumed to be
additive. We explored with GLM analysis if the effect of salt load
on dependent variable (PNat120) depends on different genetic
factors (independent variables; gene-gene interaction). In this case,
the effect size was obtained by linear regression analysis using
dummy variables based on the presence or absence of specific
combination. SPSS (version 17 for MacOS X; SPSS Inc. Chicago,
Illinois, USA) software was used for general statistical analysis.
The regional plot was generated using LocusZoom software
(http://csg.sph.umich.edu/locuszoom/). Linkage pattern was
evaluated by using Haploview 4.2 software (http://www.broad.
mit.edu/mpg/haploview). Particularly, LD bins were estimated by
Tagger algorithm implemented in Haploview.
In silico assessment of rs3790261 sequence for putative cis-acting
ESE and ESS motifs was performed with he ESE Finder 3.0 [51]
(http://rulai.cshl.edu/cgi-bin/tools/ESE3/esefinder.cgi?process =
home).
Supporting Information
Figure S1 Multidimensional scaling plot of stage 1 cohort (blue
circles), Utah residents with Northern and Western European
ancestry population from the CEPH collection (green circles) and
Tuscans (red circles) of HapMap data Release 27. The two
principal components are plotted on the axis.
(PDF)
Figure S2 Regional plot of the PRKG1 and flanking region
(chromosome 10 q11.23). The P values [2log(P)] of all genotyped
SNPs annotated with the gene structure are indicated. The best
top SNP for DDBP120 is marked with purple diamond and the rs
code is also reported. The graph was drawn with LocusZoom
software.
(PDF)
Figure S3 Map of the initial part of PRKG1 gene. The three
independent SNPs are in the red box. The LD value (r2) between a
specific pair of SNPs is shown within a corresponding ‘‘square’’.
The graph was drawn with Haploview software (http://www.
broad.mit.edu/mpg/haploview).
(PDF)
Figure S4 Multiple sequence alignment of rs7897633 region in
intron 2 of PRKG1. The highlighted area indicates SNP position.
M means A/C transversion. Sequence alignment is provided by
the UCSC Genome Browser (http://genome.ucsc.edu).
(PDF)
Figure S5 Regional plot of the SLC24A3 and flanking region
(chromosome 20 p11.23). The P values [2log(P)] of all genotyped
SNPs annotated with the gene structure are indicated. The best
top SNP for DSBP120 is marked in purple and the rs code is also
reported.
(PDF)
Figure S6 Graphic representation of SF2/ASF, SC35, SRp40
and SRp55 consensus motifs with respect to rs3790261 A/G
polymorphism. Coloured bars represent high-score motifs of
various binding factors. The height of each bar indicates the
score value, the position along the x axis indicates its location
along the sequence (SLC24A3 intron3/exon4) and the width of the
bar represents the length of the motif. The rs3790261 A/G at
position +20 in exon 4 of SLC24A3 and the relative SRp40 legend
are boxed.
(PDF)
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Figure S7 Regional plot of the SLC8A1 and flanking region
(chromosome 2 p22.1). The P values [2log(P)] of all genotyped
SNPs annotated with the gene structure are indicated. The top
ranking SNP for DSBP120 is marked in purple and the rs code is
also reported.
(PDF)
Table S1 Genotype quality control data for Illumina 318K data.
(XLS)
Table S2 Association of SNPs in PRKG1, SLC24A3 and
SLC8A1 with DDBP120, DSBP120 in stage 2 (n = 159).
(XLS)
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